ADDvise receives order worth 2,7 MSEK- Regulatory information

Report this content

ADDvise Group AB's (publ) subsidiary, Surgical Tables Inc, has received an order worth approximately 2,7 MSEK. The order was received from one of the world's three largest medtech companies. The purpose of the order is to prepare and further develop the production of a series of surgical tables for spinal fusion procedures and is an extension of the previous collaboration between the parties that was announced by ADDvise through a press release April 30th 2018.

Spinal fusion is a surgical technique that joins two or more vertebrae to eliminate movement and back pain in the patient. 

Delivery of the surgical tables will take place during 2019.  

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71 

Important information:

ADDvise Group AB is required to disclose this information under the EU Market Abuse Regulation. The information was submitted for publication on November 30th, 2018 at 10.30 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North and Mangold Fondkommission AB, +46 8 503 015 50, is the Company's Certified Adviser. Additional information is available at


Documents & Links